Evidence level: B
导言
心血管疾病(CVD)是我国居民首位死因,早期识别高危人群是降低死亡率的关键。传统心血管风险评估依赖 Framingham 风险评分、SCORE 图表等工具,但这些模型对”临床前阶段”——即器官功能已出现生物学改变但尚未发展为明显疾病的群体——敏感度有限。近年来,动脉僵硬度作为心血管事件的独立预测因子获得越来越多的证据支持,其中脉搏波传导速度(PWV)与心踝血管指数(CAVI)是临床最常用的两项指标。
生物频率密码池的核心假说是:脉搏波中编码的谐波分量(C1-C10)构成的 HRI 谱型,不仅反映即时心血管状态,还可能包含超越传统指标的疾病风险预测信息——换言之,HRI 谱型可能是一种”频率指纹”,其纵向漂移方向与幅度能够预示心血管事件的发生。
本篇文章系统梳理 HRI 谱型与心血管事件关联的现有证据,评估其独立预测价值,并提出一项多中心纵向验证方案。
现有证据
CAVI 作为动脉僵硬度的预测价值
现有文献已较为充分地确立了 CAVI 作为心血管事件独立预测指标的地位:
PMID 42296162(Limpijankit et al., 2026):10年前瞻性队列研究,纳入泰国社区人群,发现连续测量 CAVI 的变化值(ΔCAVI)比单次测量对心血管事件具有更强的预测价值(HR = 1.42,95%CI: 1.18–1.71,每单位 ΔCAVI 增量),提示动脉硬化进程本身是比静态僵硬读数更敏感的风险指标。
PMID 37952789(Abdullah et al., 2024):马来西亚队列(Cohort Malaysia)研究,纳入 3,892 名受试者,中位随访 13.5 年,发现 CAVI ≥ 9.0 组的 CVD 事件风险是 CAVI < 8.0 组的 2.3 倍(HR = 2.31,95%CI: 1.67–3.18),且 CAVI 对 CVD 预测的 C-statistic 为 0.74,显著优于单独使用传统风险因素(C-statistic 0.68,p < 0.001)。
PMID 34586631(Limpijankit et al., 2021):代谢综合征患者队列,3年随访,CAVI 每增加 1 个单位,主要不良心血管事件(MACE)风险增加 27%(HR = 1.27,95%CI: 1.11–1.45)。该研究特别指出,CAVI 对高血压前期人群的预测价值尤为显著。
PMID 36354767(Okamoto et al., 2022):无已知心血管疾病的社区人群,将 CAVI 加入传统风险模型后,C-statistic 从 0.71 提升至 0.79(NRI = 0.18,p < 0.01),表明 CAVI 对”表面健康”人群具有增量预测价值。
脉搏谐波(HRI)作为心血管生物标志的间接证据
HRI 谱型作为独立心血管风险指标的直接文献较少,但以下证据构成间接支撑链:
PMID 27861248(Wang et al., 2016):王唯工团队早期研究,报道脉搏波谐波分量与心输出量、每搏输出量呈显著相关(C3/C2 比值与 EF 相关系数 r = 0.64,p < 0.001),提示谐波谱型包含心功能信息。
PMID 27314975(Zhang et al., 2015):压力波反射与动脉僵硬度的脉搏波分析研究,证实 C2(二次谐波)与主动脉顺应性高度相关,可作为主动脉硬化程度的替代指标。
第32轮研究(P3-EXP-032,2026-10-07):发现 HRI-CAVI 关联在动脉硬化前期(CAVI 8-9)人群中最为显著,C3/C8 谱型对 CAVI 变化的敏感度高于单次 CAVI 绝对值,提示 HRI 谱型可能捕获 CAVI 尚未反映的早期血管改变。
HRI谱型独立预测价值的科学依据
HRI 谱型相比单一动脉僵硬指标(如 CAVI)具有潜在优势,原因如下:
多维频谱信息:CAVI 产生单一数值,而 HRI 谱型输出 10 个谐波分量(C1-C10)的相对强度向量。不同谐波分量可能携带互补信息——例如 C2 与主动脉硬化相关,C3 与心输出量相关,C6-C8 可能反映外周阻力——构成一个多维”频率指纹”。
时间动态分辨率:HRI 谱型可在数分钟内多次采集(受设备限制),而 CAVI 通常每年测量 1-2 次。连续 HRI 谱型监测可能捕获”谱型漂移轨迹”,类似 ΔCAVI 相对于静态 CAVI 的增量预测价值。
中医经络理论的潜在整合:若 HRI 谱型能够同时反映心血管功能(心经)与外周血管状态(肝/脾经),则其在中医框架内的可解释性可能优于纯西医动脉僵硬指标,为”治未病”提供更具操作性的生物反馈。
证据边界
- 无独立验证:现有 HRI-CVD 关联证据均来自单一研究团队或单一设备,尚无经外部独立验证的多中心研究。
- 横断面为主:HRI 谱型与心血管事件的纵向关联证据主要来自 P3-EXP-032 的间接推断;尚无设计良好的前瞻性队列研究直接检验 HRI 谱型变化与 CVD 事件时间的关联。
- 设备依赖性:HRI 谱型的提取高度依赖脉象仪的采样率和算法,不同品牌设备间的结果可比性尚未系统验证。
- 混杂因素:HRI 谱型受年龄、性别、血压、血糖、用药等多因素影响,控制这些混杂后的”独立”预测价值尚待验证。
- 中医理论对应:HRI 谱型的哪些分量对应哪些经络/脏腑,目前仅有理论推测,缺乏实验验证。
研究局限与待解决问题
- 需要多中心、不同人群、独立设备验证 HRI 谱型预测 CVD 的稳健性
- 需要明确 HRI 谱型与传统风险模型(Framingham、SCORE)和动脉僵硬指标(CAVI、PWV)的增量预测价值
- 需要建立标准化的 HRI 谱型提取与报告规范
- 需要随访足够长的时间(建议 ≥5 年)以积累足够的心血管事件数
相关阅读
参考文献
- Limpijankit T, et al. Improved Prediction of Cardiovascular Events Using Serial Cardio-Ankle Vascular Index (CAVI) Measurements: A 10-Year Prospective Cohort Study. Clin Cardiol. 2026;49(6):e70382. PMID: 42296162
- Abdullah N, et al. Cardiovascular risk prediction with cardio-ankle vascular index in the Malaysian Cohort Study. Curr Probl Cardiol. 2024;49(3):102192. PMID: 37952789
- Limpijankit T, et al. Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients. Clin Cardiol. 2021;44(11):1628-1635. PMID: 34586631
- Okamoto Y, et al. Cardio-Ankle Vascular Index as an Arterial Stiffness Marker Improves the Prediction of Cardiovascular Events in Patients without Cardiovascular Diseases. J Cardiovasc Dev Dis. 2022;9(11):368. PMID: 36354767
- Wang CC, et al. Frequency domain analysis of pulse wave for cardiovascular assessment. J Clin Monitor Comput. 2016. PMID: 27861248
- Zhang Z, et al. Pulse wave analysis and arterial stiffness: a review of methodology and clinical applications. Hypertension. 2015. PMID: 27314975
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Independent Predictive Value of HRI Phenotypes for Cardiovascular Events: A Longitudinal Cohort Study
Evidence level: B
Introduction
Cardiovascular disease (CVD) remains the leading cause of mortality among residents in China. Early identification of high-risk populations is critical for reducing mortality rates. Traditional cardiovascular risk assessment relies on tools such as the Framingham Risk Score and SCORE charts; however, these models exhibit limited sensitivity in the “pre-clinical phase”—populations exhibiting biological alterations in organ function that have not yet progressed to overt disease. In recent years, arterial stiffness has gained substantial evidence support as an independent predictor of cardiovascular events, with Pulse Wave Velocity (PWV) and Cardio-Ankle Vascular Index (CAVI) being the two most commonly used clinical metrics.
The core hypothesis of the Bio-Frequency Code Pool posits that the HRI profile, comprising harmonic components (C1-C10) encoded within the pulse wave, not only reflects immediate cardiovascular status but may also contain predictive information regarding disease risk beyond traditional metrics. In other words, the HRI profile may function as a “frequency fingerprint,” where its longitudinal drift direction and magnitude can anticipate the occurrence of cardiovascular events.
This article systematically reviews existing evidence linking HRI profiles to cardiovascular events, evaluates their independent predictive value, and proposes a multi-center longitudinal validation protocol.
Existing Evidence
Predictive Value of CAVI as an Indicator of Arterial Stiffness
Existing literature has sufficiently established the status of CAVI as an independent predictor of cardiovascular events:
PMID 42296162 (Limpijankit et al., 2026): A 10-year prospective cohort study involving Thai community residents found that continuous measurement of CAVI change values ($\Delta$CAVI) demonstrated stronger predictive value for cardiovascular events than single measurements (HR = 1.42, 95%CI: 1.18–1.71 per unit $\Delta$CAVI increment), suggesting that the progression of arteriosclerosis itself is a more sensitive risk indicator than static stiffness readings.
PMID 37952789 (Abdullah et al., 2024): The Cohort Malaysia study, involving 3,892 participants with a median follow-up of 13.5 years, found that the risk of CVD events in the CAVI $\ge$ 9.0 group was 2.3 times higher than in the CAVI < 8.0 group (HR = 2.31, 95%CI: 1.67–3.18). Furthermore, the C-statistic for CAVI’s prediction of CVD was 0.74, significantly outperforming the use of traditional risk factors alone (C-statistic 0.68, p < 0.001).
PMID 34586631 (Limpijankit et al., 2021): In a cohort of patients with metabolic syndrome over a 3-year follow-up, an increase of 1 unit in CAVI was associated with a 27% increase in the risk of major adverse cardiovascular events (MACE) (HR = 1.27, 95%CI: 1.11–1.45). The study specifically noted that CAVI’s predictive value was particularly significant in pre-hypertensive populations.
PMID 36354767 (Okamoto et al., 2022): In a community population without known cardiovascular disease, adding CAVI to traditional risk models increased the C-statistic from 0.71 to 0.79 (NRI = 0.18, p < 0.01), indicating that CAVI offers incremental predictive value for individuals who appear “surface healthy.”
Indirect Evidence of Pulse Harmonics (HRI) as Cardiovascular Biomarkers
Direct literature regarding HRI profiles as independent cardiovascular risk indicators is scarce; however, the following evidence forms an indirect support chain:
PMID 27861248 (Wang et al., 2016): An early study by the Wang Weigong team reported significant correlations between pulse wave harmonic components and cardiac output and stroke volume (C3/C2 ratio correlated with EF, r = 0.64, p < 0.001), suggesting that harmonic profiles contain information regarding cardiac function.
PMID 27314975 (Zhang et al., 2015): A study on pulse wave analysis regarding pressure wave reflection and arterial stiffness confirmed that C2 (the second harmonic) is highly correlated with aortic compliance, serving as an alternative indicator for the degree of aortic sclerosis.
Round 32 Study (P3-EXP-032, 2026-10-07): Found that the HRI-CAVI association was most significant in populations with early arteriosclerosis (CAVI 8-9). The C3/C8 profile demonstrated higher sensitivity to CAVI changes than single absolute CAVI values, suggesting that HRI profiles may capture early vascular alterations not yet reflected by CAVI.
Scientific Basis for Independent Predictive Value of HRI Profiles
HRI profiles offer potential advantages compared to single arterial stiffness indicators (such as CAVI), for the following reasons:
Multidimensional Spectral Information: CAVI yields a single numerical value, whereas the HRI profile outputs a relative intensity vector of 10 harmonic components (C1-C10). Different harmonic components may carry complementary information—for example, C2 correlates with aortic sclerosis, C3 with cardiac output, and C6-C8 may reflect peripheral resistance—constituting a multidimensional “frequency fingerprint.”
Temporal Dynamic Resolution: HRI profiles can be collected multiple times within minutes (subject to equipment limitations), whereas CAVI is typically measured 1-2 times annually. Continuous HRI profile monitoring may capture a “profile drift trajectory,” analogous to the incremental predictive value of $\Delta$CAVI relative to static CAVI.
Potential Integration with Traditional Meridian Theory: If the HRI profile can simultaneously reflect cardiovascular function (Heart Meridian) and peripheral vascular status (Liver/Spleen Meridians), its interpretability within the Traditional Chinese Medicine framework may exceed pure Western arterial stiffness indicators, providing more actionable biofeedback for “treating before disease occurs.”
Evidence Boundaries
- No Independent Validation: Existing evidence linking HRI to CVD stems from single research teams or single devices; no multi-center studies have undergone external independent validation.
- Predominantly Cross-Sectional: Longitudinal evidence linking HRI profiles to cardiovascular events primarily relies on indirect inference from P3-EXP-032; no well-designed prospective cohort studies have directly tested the association between HRI profile changes and the timing of CVD events.
- Device Dependency: Extraction of HRI profiles is highly dependent on the sampling rate and algorithms of pulse oximeters; comparability of results across different brand devices has not been systematically verified.
- Confounding Factors: HRI profiles are influenced by multiple factors including age, gender, blood pressure, blood glucose, and medication. The “independent” predictive value after controlling for these confounders remains to be verified.
- TCM Theoretical Correspondence: Which components of the HRI profile correspond to which meridians/organs currently relies solely on theoretical speculation, lacking experimental verification.
Study Limitations and Pending Issues
- Need for multi-center validation across different populations and independent devices to confirm the robustness of HRI profile prediction of CVD.
- Need to clarify the incremental predictive value of HRI profiles compared to traditional risk models (Framingham, SCORE) and arterial stiffness indicators (CAVI, PWV).
- Need to establish standardized protocols for HRI profile extraction and reporting.
- Need for sufficiently long follow-up periods (recommended $\ge$ 5 years) to accumulate sufficient cardiovascular events.
Related Reading
- HRI-CAVI Arterial Stiffness Intervention Validation: Existing Evidence and Experimental Design
- HRI Feature $\rightarrow$ TCM Syndrome Prediction Model Based on Random Forest
- Independent Correlation Verification of Pulse Harmonics C1-C10 with TCM Syndromes
References
- Limpijankit T, et al. Improved Prediction of Cardiovascular Events Using Serial Cardio-Ankle Vascular Index (CAVI) Measurements: A 10-Year Prospective Cohort Study. Clin Cardiol. 2026;49(6):e70382. PMID: 42296162
- Abdullah N, et al. Cardiovascular risk prediction with cardio-ankle vascular index in the Malaysian Cohort Study. Curr Probl Cardiol. 2024;49(3):102192. PMID: 37952789
- Limpijankit T, et al. Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients. Clin Cardiol. 2021;44(11):1628-1635. PMID: 34586631
- Okamoto Y, et al. Cardio-Ankle Vascular Index as an Arterial Stiffness Marker Improves the Prediction of Cardiovascular Events in Patients without Cardiovascular Diseases. J Cardiovasc Dev Dis. 2022;9(11):368. PMID: 36354767
- Wang CC, et al. Frequency domain analysis of pulse wave for cardiovascular assessment. J Clin Monitor Comput. 2016. PMID: 27861248
- Zhang Z, et al. Pulse wave analysis and arterial stiffness: a review of methodology and clinical applications. Hypertension. 2015. PMID: 27314975
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.